Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to MBOAT1" is a non-coding RNA transcript annotated on the opposite strand of the MBOAT1 gene. Antisense transcripts are a widespread feature of eukaryotic genomes and frequently act at the RNA level to regulate the expression, processing, or stability of their sense gene counterparts. They are not classified as conventional therapeutic targets such as receptors, enzymes, or transporters. No evidence supports its involvement in human disease or direct interaction with drugs. Its biological function, if any, would likely be related to the modulation of MBOAT1 gene expression, as antisense transcripts can influence chromatin structure and the transcriptional dynamics of their sense partners[1]. There is no indication from current databases that this entity is misspelled, but as a non-coding RNA (and not a protein target), it is not considered a bona fide drug discovery target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to MBOAT1 (ENSG00000227803).